4D Biomaterials develops novel solutions for the targeted and controlled regeneration of human tissue.
4D Biomaterials has raised €1.9M across 1 funding round from 3 investors, most recently a round in Jul 2021. Based in Nottingham, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-29 | Other |
| €1.9M |
| DSW Ventures,MEIF Proof-of-Concept & Early Stage Fund,SFC Capital |
| View deal → |
